Advanced Search

ICD-10-PCS code List for Anti-inflammatory

ICD-10-PCS code List for Anti-inflammatory is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach

Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach

Introduction of Other Antineoplastic into Peripheral Vein, Open Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach

Introduction of Clofarabine into Peripheral Vein, Open Approach

Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open

Introduction of Other Thrombolytic into Peripheral Vein, Open Approach

Introduction of Oxazolidinones into Peripheral Vein, Open Approach

Introduction of Other Anti-infective into Peripheral Vein, Open Approach

Introduction of Anti-inflammatory into Peripheral Vein, Open Approach

Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach

Introduction of Nutritional Substance into Peripheral Vein, Open Approach

Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach

Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach

Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach

Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach

Introduction of Radioactive Substance into Peripheral Vein, Open Approach

Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach

Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach

Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach

Introduction of Antiarrhythmic into Peripheral Vein, Open Approach

Introduction of Destructive Agent into Peripheral Vein, Open Approach

Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

Introduction of Insulin into Peripheral Vein, Open Approach

Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach

Introduction of Other Hormone into Peripheral Vein, Open Approach

Introduction of Immunostimulator into Peripheral Vein, Open

Introduction of Immunosuppressive into Peripheral Vein, Open

Introduction of Vasopressor into Peripheral Vein, Open Approach

Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach

Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach

Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous

Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach

Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach

Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach

Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach

Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach

Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach

Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach

Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach

Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach

Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach

Introduction of Other Therapeutic Monoclonal Antibody into Peripheral Vein, Percutaneous Approach

Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach

Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach

Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach

Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach

Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach

Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

Introduction of Insulin into Peripheral Vein, Percutaneous Approach

Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach

Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach

Introduction of Immunostimulator into Peripheral Vein, Percutaneous

Introduction of Immunosuppressive into Peripheral Vein, Percutaneous

Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach